Skip to content
The NDSS is administered by Diabetes Australia
Read aloud

Important safety information for diabetes patients in possession of a GlucaGen® HypoKit

Published:

Novo Nordisk Pharmaceuticals Pty Ltd is recalling 4 batches of GlucaGen HypoKit in Australia. The GlucaGen HypoKit is indicated for the ‘treatment of severe hypoglycaemic reactions which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents’.

Novo Nordisk conducted an investigation showing a small number of needles were detached from the pre-filled syringe supplied in certain batches of the GlucaGen HypoKit. To protect patient safety, Novo Nordisk is recalling all products in the affected batches from wholesalers, pharmacies and patients in Australia.

The recalled GlucaGen HypoKit batch numbers are:

FS6X465

FS6X536

FS6X715

FS6X891

With expiry date: 31-Aug-2017

If you are in possession of a GlucaGen HypoKit with one of the listed batch numbers, return your GlucaGen HypoKit product to your pharmacy. You will be given a free replacement GlucaGen HypoKit.

To view the original TGA announcement, please visit their website.

If you have any questions regarding this recall, please contact NovoCare Customer Care Centre on 1800 668 626 for further information.